The Globe and Mail

Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy

Sarasota, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the “Company”) a clinical-stage biotechnology company developing brain-targeted therapeutics through ...

North Shore University Hospital first in NY to use new test to detect 'invisible' brain injuries

"This rapid turnaround to assess for brain injuries is a game-changer." ...
Clinical Advisor

Beyond the Hit: The Complex Pathophysiology and Management of Sport-Related Concussions

Sport-related concussions are mild traumatic brain injuries that demand timely recognition and management. This review explores current evidence on pathophysiology, diagnosis, and treatment strategies ...
Long Island Press

North Shore first in New York to use new blood test for brain injury

North Shore University Hospital has started using a new rapid blood test that can help emergency department physicians ...